chr1-154869723-GGCT-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_002249.6(KCNN3):βc.239_241delβ(p.Gln80del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0431 in 1,505,328 control chromosomes in the GnomAD database, including 408 homozygotes. Variant has been reported in ClinVar as Benign (β β ).
Frequency
Genomes: π 0.045 ( 151 hom., cov: 0)
Exomes π: 0.043 ( 257 hom. )
Consequence
KCNN3
NM_002249.6 inframe_deletion
NM_002249.6 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.12
Genes affected
KCNN3 (HGNC:6292): (potassium calcium-activated channel subfamily N member 3) Action potentials in vertebrate neurons are followed by an afterhyperpolarization (AHP) that may persist for several seconds and may have profound consequences for the firing pattern of the neuron. Each component of the AHP is kinetically distinct and is mediated by different calcium-activated potassium channels. This gene belongs to the KCNN family of potassium channels. It encodes an integral membrane protein that forms a voltage-independent calcium-activated channel, which is thought to regulate neuronal excitability by contributing to the slow component of synaptic AHP. This gene contains two CAG repeat regions in the coding sequence. It was thought that expansion of one or both of these repeats could lead to an increased susceptibility to schizophrenia or bipolar disorder, but studies indicate that this is probably not the case. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-154869723-GGCT-G is Benign according to our data. Variant chr1-154869723-GGCT-G is described in ClinVar as [Benign]. Clinvar id is 403004.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0575 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNN3 | NM_002249.6 | c.239_241del | p.Gln80del | inframe_deletion | 1/8 | ENST00000271915.9 | NP_002240.3 | |
KCNN3 | NM_001204087.2 | c.239_241del | p.Gln80del | inframe_deletion | 1/9 | NP_001191016.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNN3 | ENST00000271915.9 | c.239_241del | p.Gln80del | inframe_deletion | 1/8 | 1 | NM_002249.6 | ENSP00000271915 | P1 | |
KCNN3 | ENST00000618040.4 | c.239_241del | p.Gln80del | inframe_deletion | 1/9 | 5 | ENSP00000481848 |
Frequencies
GnomAD3 genomes AF: 0.0454 AC: 6409AN: 141212Hom.: 151 Cov.: 0
GnomAD3 genomes
AF:
AC:
6409
AN:
141212
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0429 AC: 58521AN: 1364014Hom.: 257 AF XY: 0.0425 AC XY: 28625AN XY: 674284
GnomAD4 exome
AF:
AC:
58521
AN:
1364014
Hom.:
AF XY:
AC XY:
28625
AN XY:
674284
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0454 AC: 6415AN: 141314Hom.: 151 Cov.: 0 AF XY: 0.0450 AC XY: 3058AN XY: 67988
GnomAD4 genome
AF:
AC:
6415
AN:
141314
Hom.:
Cov.:
0
AF XY:
AC XY:
3058
AN XY:
67988
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency (18 homozygotes in ExAC) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at